// company-profile
Kalaris Therapeutics, Inc. Insider Trading
KLRSEvery SEC Form 4 insider trading filing for Kalaris Therapeutics, Inc. (KLRS) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=KLRS" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
Recent insider activity is bullish. Over the last 30 days, 2 insiders purchased shares. Buying was led by KEATING LAURIE.
// 90-day insight
Over the last 90 days, Kalaris Therapeutics, Inc. insiders bought $1.2M across 10 transactions with no open-market sales.
- Most active insider: AKKARAJU SRINIVAS with 5 transactions totaling $1.2M.
- Largest single purchase: $1.2M by AKKARAJU SRINIVAS on May 20, 2026.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Kalaris Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 1, 2026 | KEATING LAURIE | KLRS | Award | 18,000 | $0.00 | $0K |
| Jul 20, 2026 | Bayko Liisa Ann | KLRS | Award | 220,000 | $0.00 | $0K |
| Jun 3, 2026 | Dybbs Michael | KLRS | Award | 9,000 | $0.00 | $0K |
| Jun 3, 2026 | Hallal David | KLRS | Award | 9,000 | $0.00 | $0K |
| Jun 3, 2026 | ADAMIS ANTHONY P | KLRS | Award | 9,000 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →